{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:06:54Z","timestamp":1782846414674,"version":"3.54.5"},"reference-count":140,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Multiple long-term conditions (MLTCs) require complex and prolonged treatment regimens. Remission in long-term conditions (LTCs) is important for understanding disease progression and evaluating treatment effectiveness. Electronic health records (EHRs) are increasingly used to monitor clinical outcomes, but how remission is defined within EHRs remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to summarize and collate the previous literature on how remission of LTCs has been defined in EHRs.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Systematic electronic searches were performed on OVID MEDLINE, Embase, CINAHL EBSCO, the Cochrane Library, and the Bielefeld Academic Search Engine for eligible studies published from inception to November 27, 2025. Quantitative studies, published in any language, on adult populations, and using EHRs to assess remission of LTCs, were eligible for inclusion. Studies that did not clearly define remission and studies on cancer remission were excluded. Data were extracted from each eligible study using a structured table. Risk of bias was not assessed, in line with scoping review methodology. A narrative approach was taken to summarize and present data from the included studies. The number and characteristics of studies were described, both overall and by condition. Findings were discussed with clinicians and data experts to ensure applicability in clinical practice.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Ninety-one studies were included. Sample sizes ranged from 12 to 72.9 million adults. Studies were conducted in 18 countries, with the majority being from the United States. The majority of included studies used a cohort study design. Studies assessed how remission was defined in 12 LTCs, including inflammatory bowel disease (41\/91, 45.1%), type 2 diabetes (n=15, 16.5%), depression (n=15, 16.5%), alcohol or drug misuse (n=8, 8.8%), asthma (n=3, 3.3%), multiple sclerosis (n=3, 3.3%), epilepsy (n=1, 1.1%), anemia (n=, chronic kidney disease (n=, autoimmune pancreatitis (n=, hypertension (n=, heart failure (n=, and MLTC (n=. Remission was typically defined using a combination of clinical codes (n=, validated rating scales (n=, biochemical markers (n=, absence of symptoms (n=, absence of condition-specific events (eg, hospital admissions; n=, and cessation of pharmacological treatments (n=. There was substantial variation in the criteria and duration of follow-up used to define remission across studies.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This review demonstrates that remission of LTCs can be identified and operationalized within EHRs, although remission criteria varied across studies. The review extends the literature on remission in EHRs by combining evidence synthesis and consultation with clinical and data experts to propose standardized comprehensive definitions to reliably define and implement remission of multiple LTCs in EHR-based research. This will allow cross-study comparisons and present an opportunity to advance understanding of disease trajectories and improve evaluation and monitoring of patient outcomes. Further research may apply, compare, and evaluate standardized definitions across different data sources to assess generalizability and further improve our understanding of remission of LTCs.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/80796","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:40:07Z","timestamp":1775803207000},"page":"e80796-e80796","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Remission of Long-Term Conditions Through Electronic Health Records: Scoping Review"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-1791","authenticated-orcid":false,"given":"Hilda","family":"Hounkpatin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1489-8704","authenticated-orcid":false,"given":"Benjamin","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-5095","authenticated-orcid":false,"given":"Margaret","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-8790","authenticated-orcid":false,"given":"Rohini","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-7437","authenticated-orcid":false,"given":"Beth","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-443X","authenticated-orcid":false,"given":"Hajira","family":"Dambha-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"R1","unstructured":"Multimorbidity: technical series on safer primary care. World Health Organization. 2016. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/695cc0ce-75ea-4163-8bb5-3bc9733fa63f\/content [Accessed 26-04-2026]"},{"key":"R2","unstructured":"Multimorbidity: clinical assessment and management. National Institute of Health and Care Excellence. 2016. URL: https:\/\/www.nice.org.uk\/guidance\/ng56 [Accessed 26-04-2026]"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03021-3","article-title":"Healthcare fragmentation, multimorbidity, potentially inappropriate medication, and mortality: a Danish nationwide cohort study","volume":"21","author":"Prior","journal-title":"BMC Med"},{"issue":"706","key":"R4","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.3399\/BJGP.2020.0883","article-title":"Treatment burden for patients with multimorbidity: cross-sectional study with exploration of a single-item measure","volume":"71","author":"Morris","journal-title":"Br J Gen Pract"},{"issue":"11","key":"R5","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s11136-023-03473-3","article-title":"Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study","volume":"32","author":"Gebreyohannes","journal-title":"Qual Life Res"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12875-015-0344-4","article-title":"Challenges of managing people with multimorbidity in today\u2019s healthcare systems","volume":"16","author":"Moffat","journal-title":"BMC Fam Pract"},{"issue":"7","key":"R7","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac155","article-title":"Association between multimorbidity and hospitalization in older adults: systematic review and meta-analysis","volume":"51","author":"Rodrigues","journal-title":"Age Ageing"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2024-001016","article-title":"Combinations of multiple long term conditions and risk of hospital admission or death during winter 2021-22 in England: population based cohort study","volume":"3","author":"Islam","journal-title":"BMJ Med"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003931","article-title":"Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: a comparison of longitudinal cohort studies","volume":"19","author":"Hanlon","journal-title":"PLoS Med"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/joim.13567","article-title":"Simple approaches to characterising multiple long-term conditions (multimorbidity) and rates of emergency hospital admission: findings from 495,465 UK Biobank participants","volume":"293","author":"Dodds","journal-title":"J Intern Med"},{"issue":"741","key":"R11","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.3399\/BJGP.2023.0163","article-title":"A primary care research agenda for multiple long-term conditions: a Delphi study","volume":"74","author":"Stokes","journal-title":"Br J Gen Pract"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00125-023-06048-6","article-title":"Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study","volume":"67","author":"Gregg","journal-title":"Diabetologia"},{"issue":"8","key":"R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290791","article-title":"Type 2 diabetes remission trajectories and variation in risk of diabetes complications: a population-based cohort study","volume":"18","author":"Dambha-Miller","journal-title":"PLoS One"},{"issue":"11","key":"R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003817","article-title":"Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: a Swedish nationwide registry-based cohort study","volume":"18","author":"Stenberg","journal-title":"PLoS Med"},{"issue":"6","key":"R15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1185\/03007995.2015.1029893","article-title":"Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study","volume":"31","author":"Dennehy","journal-title":"Curr Med Res Opin"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1418342","article-title":"Remission from depression is associated with improved quality of life and preserved exercise capacity in adults with congenital heart disease","volume":"11","author":"Fillies","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"R17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/jamiaopen\/ooaa044","article-title":"Patient-centered care and the electronic health record: exploring functionality and gaps","volume":"3","author":"Butler","journal-title":"JAMIA Open"},{"issue":"10","key":"R18","first-page":"846","volume":"61","author":"Manca","journal-title":"Can Fam Physician"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.1038\/s41598-025-92940-7","article-title":"Understanding hospital activity and outcomes for people with multimorbidity using electronic health records","volume":"15","author":"Georgiev","journal-title":"Sci Rep"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","journal-title":"Int J Soc Res Methodol"},{"issue":"7","key":"R21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","journal-title":"Ann Intern Med"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000247","article-title":"Measuring multimorbidity in research: Delphi consensus study","volume":"1","author":"Ho","journal-title":"BMJ Med"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.3310\/nihropenres.1115210.1","article-title":"Artificial intelligence for multiple long-term conditions (AIM): a consensus statement from the NIHR AIM consortia","author":"Dambha-Miller","journal-title":"NIHR Open Research"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","journal-title":"Syst Rev"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis","volume":"57","author":"Chowdhury","journal-title":"eClinicalMedicine"},{"issue":"2","key":"R26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/nuf.12558","article-title":"A concept analysis of remission within the domain of cancer survivorship","volume":"56","author":"Vena","journal-title":"Nurs Forum"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","journal-title":"Int J Epidemiol"},{"issue":"5","key":"R28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","article-title":"Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure","volume":"51","author":"Tang","journal-title":"J Am Coll Cardiol"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Howarth P Lim K Corbridge T et al. Real-world assessment of clinical remission in asthma with biologics. Presented at: ERS Congress 2024; Sep 7-11, 2024. [doi: 10.1183\/13993003.congress-2024.PA2182]","DOI":"10.1183\/13993003.congress-2024.PA2182"},{"issue":"2","key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.11.325","article-title":"A real-world analysis of key asthma remission components in patients treated with benralizumab: the ZEPHYR-4 study","volume":"153","author":"Carstens","journal-title":"J Allergy Clin Immunol"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A1368","article-title":"Evaluation of clinical remission indicators in asthma patients treated with biologics in a real-world setting [abstract]","volume":"209","author":"Lim","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"R32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/2150131916638329","article-title":"The impact of posttraumatic stress disorder on the 6-month outcomes in collaborative care management for depression","volume":"7","author":"Angstman","journal-title":"J Prim Care Community Health"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.07.030","article-title":"How well do patient activation scores predict depression outcomes one year later?","volume":"169","author":"Sacks","journal-title":"J Affect Disord"},{"issue":"7","key":"R34","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/jgs.13483","article-title":"Conformance to depression process measures of medicare part B beneficiaries in primary care settings","volume":"63","author":"Pfoh","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"R35","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1016\/j.jagp.2019.01.104","article-title":"The effectiveness of problem adaptation therapy (PATH) in a culture and language rich community","volume":"27","author":"Eguchi","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"R36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1176\/appi.ps.201900295","article-title":"Defining success in measurement-based care for depression: a comparison of common metrics","volume":"71","author":"Coley","journal-title":"PS"},{"issue":"2","key":"R37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/YCT.0000000000000895","article-title":"Electroconvulsive therapy anesthetic choice and clinical outcomes","volume":"39","author":"Li","journal-title":"J ECT"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115196","article-title":"Outcomes for treatment of depression in the Veterans Health Administration: rates of response and remission calculated from clinical and survey data","volume":"324","author":"Liebmann","journal-title":"Psychiatry Res"},{"issue":"4","key":"R39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.mayocpiqo.2023.05.005","article-title":"Comparison of ambulatory quality measures between shared practice panels and independent practice panels","volume":"7","author":"Whiting","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"7","key":"R40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64968","article-title":"Multipronged electronic health record analysis of antidepressant effectiveness on depression remission in patients with concurrent depression and irritable bowel syndrome","volume":"16","author":"Deng","journal-title":"Cureus"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23m14984","article-title":"Clinical outcomes of intravenous ketamine treatment for depression in the VA health system","volume":"85","author":"Pfeiffer","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41398-025-03380-w","article-title":"Predictive modeling of response to repetitive transcranial magnetic stimulation in treatment-resistant depression","volume":"15","author":"Benster","journal-title":"Transl Psychiatry"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201110002-01297","article-title":"Clinical remission is predictive of endoscopic remission and clinical disease activity is predictive of endoscopic disease activity in patients with ulcerative colitis at the time of surveillance colonoscopy","volume":"106","author":"Blonski","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"R44","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(13)61575-9","article-title":"Su1208 Effectiveness of split-dose certolizumab pegol for the treatment of Crohn\u2019s disease: experience at a tertiary care center","volume":"144","author":"Kane","journal-title":"Gastroenterology"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201410002-01649","article-title":"Efficacy of high-dose versus low-dose methotrexate in combination therapy for inflammatory bowel disease","volume":"109","author":"Colman","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"R46","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1097\/MIB.0000000000000456","article-title":"Use of intravenous immunoglobulin for patients with inflammatory bowel disease with contraindications or who are unresponsive to conventional treatments","volume":"21","author":"Merkley","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"R47","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.14309\/01.ajg.0000705608.97193.ba","article-title":"S0890 Can IBD medications counteract the negative effects of a deleterious, high sugar diet?","volume":"115","author":"Ahsan","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"R48","first-page":"S","volume":"158","author":"Vachon","journal-title":"Gastroenterology"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12144","article-title":"Vedolizumab in real practice: experience in a tertiary hospital","volume":"9","author":"Fernandez-Cano","journal-title":"UEG J"},{"issue":"2","key":"R50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jgh3.12475","article-title":"Long\u2010term outcomes of perianal fistulizing Crohn\u2019s disease in the biologic era","volume":"5","author":"Lee","journal-title":"JGH Open"},{"issue":"4","key":"R51","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s10620-022-07716-0","article-title":"Endo-histologic normalization is achievable with tofacitinib and is associated with improved clinical outcomes","volume":"68","author":"Cohen","journal-title":"Dig Dis Sci"},{"key":"R52","volume":"162","author":"Chugh","journal-title":"Gastroenterology"},{"issue":"10S","key":"R53","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.14309\/01.ajg.0000860284.16240.9f","article-title":"S911 Real world outcomes of tofacitinib for ulcerative colitis at 52 and 78 weeks","volume":"117","author":"Dalal","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"R54","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(22)61918-8","article-title":"Mo1546: One and two-year outcomes after ustekinumab dose intensification for inflammatory bowel diseases","volume":"162","author":"Dalal","journal-title":"Gastroenterology"},{"issue":"2","key":"R55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MCG.0000000000001834","article-title":"Predictors and etiologies of clinical relapse among patients with ulcerative colitis in deep remission","volume":"58","author":"Zeina","journal-title":"J Clin Gastroenterol"},{"issue":"10S","key":"R56","doi-asserted-by":"publisher","first-page":"S876","DOI":"10.14309\/01.ajg.0001034292.46400.5e","article-title":"S1231\u2003Real-world effectiveness and onset of action of vedolizumab as a first-line biologic in biologic-na\u00efve patients with ulcerative colitis","volume":"119","author":"Anyanwu","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"R57","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(24)03105-6","article-title":"Mo1866 Real world efficacy of risankizumab in Crohn\u2019s disease patients with prior exposure to ustekinumab","volume":"166","author":"Chugh","journal-title":"Gastroenterology"},{"issue":"8","key":"R58","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.14309\/ajg.0000000000002746","article-title":"One-year comparative effectiveness of upadacitinib vs tofacitinib for ulcerative colitis: a multicenter cohort study","volume":"119","author":"Dalal","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"R59","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(24)03790-9","article-title":"Tu1889 Real-world effectiveness and safety of ozanimod in ulcerative colitis: a multicenter study","volume":"166","author":"Lieto","journal-title":"Gastroenterology"},{"issue":"10S","key":"R60","doi-asserted-by":"publisher","first-page":"S921","DOI":"10.14309\/01.ajg.0001034520.61834.16","article-title":"S1288\u2003Real-world effectiveness of ozanimod for ulcerative colitis in patients with prior advanced therapy exposure: a multicenter study","volume":"119","author":"Scalzo","journal-title":"Am J Gastroenterol"},{"key":"R61","author":"Gold","journal-title":"Gastroenterology"},{"issue":"4","key":"R62","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/j.orcp.2012.08.196","article-title":"Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults","volume":"7","author":"Arterburn","journal-title":"Obes Res Clin Pract"},{"issue":"1","key":"R63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S2213-8587(13)70070-6","article-title":"Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study","volume":"2","author":"Still","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"R64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0000000000000588","article-title":"Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis","volume":"261","author":"Wood","journal-title":"Ann Surg"},{"issue":"3","key":"R65","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00464-016-5129-x","article-title":"The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery","volume":"31","author":"Zaman","journal-title":"Surg Endosc"},{"issue":"Supplement_1","key":"R66","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2337\/db18-2101-P","article-title":"Metabolic surgery counseling, diabetes remission, and A1C control in patients with diabetes and obesity","volume":"67","author":"Chang","journal-title":"Diabetes"},{"issue":"5","key":"R67","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.soard.2018.12.020","article-title":"DiaRem2: incorporating duration of diabetes to improve prediction of diabetes remission after metabolic surgery","volume":"15","author":"Still","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"R68","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s11695-023-06622-2","article-title":"Diabetes mellitus remission in patients with BMI > 50 kg\/m after bariatric surgeries: a real-world multi-centered study","volume":"33","author":"Ghusn","journal-title":"OBES SURG"},{"issue":"10","key":"R69","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc25-0530","article-title":"Clinical and demographic characteristics associated with diabetes remission in six integrated health care systems: a retrospective cohort study","volume":"48","author":"Thapa","journal-title":"Diabetes Care"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.04.006","article-title":"Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV","volume":"78","author":"Williams","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"R71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.15288\/jsad.2020.81.436","article-title":"Remission from unhealthy drinking among patients with an alcohol use disorder: a longitudinal study using systematic, primary care-based alcohol screening data","volume":"81","author":"Palzes","journal-title":"J Stud Alcohol Drugs"},{"issue":"9","key":"R72","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1038\/s41380-020-01011-y","article-title":"Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses","volume":"26","author":"Zhou","journal-title":"Mol Psychiatry"},{"issue":"1","key":"R73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/add.16338","article-title":"Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: challenges and opportunities","volume":"119","author":"Osterhage","journal-title":"Addiction"},{"issue":"4","key":"R74","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/add.16715","article-title":"Artificial intelligence\u2010based drug repurposing with electronic health record clinical corroboration: a case for ketamine as a potential treatment for amphetamine\u2010type stimulant use disorder","volume":"120","author":"Gao","journal-title":"Addiction"},{"issue":"s1","key":"R75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/cts.2024.716","article-title":"25 The association of a documented prescription of medication for opioid use disorder (MOUD) during pregnancy with maternal outcomes","volume":"9","author":"Hailer","journal-title":"J Clin Trans Sci"},{"issue":"1","key":"R76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/STROKEAHA.122.040331","article-title":"Association of depression onset and treatment with blood pressure control after intracerebral hemorrhage","volume":"54","author":"Keins","journal-title":"Stroke"},{"issue":"Supplement_1","key":"R77","doi-asserted-by":"publisher","first-page":"gfae069","DOI":"10.1093\/ndt\/gfae069.627","article-title":"#1321 Long term outcomes in people with fluctuating criteria for the diagnosis of chronic kidney disease","volume":"39","author":"Taal","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"R78","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03138-5","article-title":"Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study","volume":"21","author":"De Giorgi","journal-title":"BMC Med"},{"issue":"12","key":"R79","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032551","article-title":"Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records","volume":"9","author":"Powell","journal-title":"BMJ Open"},{"issue":"Supplement_1","key":"R80","doi-asserted-by":"publisher","first-page":"S270","DOI":"10.1093\/ecco-jcc\/jjy222.461","article-title":"P337 Switching from originator infliximab to CT-P13: single-centre experience from the UK","volume":"13","author":"Bhandare","journal-title":"J Crohns Colitis"},{"issue":"2","key":"R81","doi-asserted-by":"publisher","first-page":"170","DOI":"10.20524\/aog.2020.0447","article-title":"Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience","volume":"33","author":"Ibraheim","journal-title":"Ann Gastroenterol"},{"issue":"Supplement_1","key":"R82","doi-asserted-by":"publisher","first-page":"i465","DOI":"10.1093\/ecco-jcc\/jjab232.631","article-title":"P504 Prospective analysis of micronutrient status and disease course in inflammatory bowel disease","volume":"16","author":"Brownson","journal-title":"J Crohns Colitis"},{"issue":"4","key":"R83","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/flgastro-2022-102309","article-title":"How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?","volume":"14","author":"Meade","journal-title":"Frontline Gastroenterol"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241258372","article-title":"Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis","volume":"17","author":"Gros","journal-title":"Ther Adv Gastroenterol"},{"issue":"4","key":"R85","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v16.i4.110273","article-title":"Risankizumab is effective following ustekinumab failure in Crohn\u2019s disease: a real-world study from a tertiary center","volume":"16","author":"Colwill","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"10","key":"R86","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1007\/s11695-016-2103-6","article-title":"Effect of contemporary bariatric surgical procedures on type 2 diabetes remission. a population-based matched cohort study","volume":"26","author":"Gulliford","journal-title":"Obes Surg"},{"key":"R87","unstructured":"Griffiths BP Mehar S Blangiardo M et al. Evaluating the effectiveness of REWIND (reducing weight with intensive dietary support) on type 2 diabetes remission. SSRN. URL: https:\/\/ssrn.com\/abstract=5169449 [Accessed 28-04-2026]"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.09.005","article-title":"Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population","volume":"140","author":"Ledwaba-Chapman","journal-title":"J Clin Epidemiol"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1075631","article-title":"Efficacy of tolvaptan on the short and mid-term prognosis in elderly patients with acute heart failure coexisting with oliguria: a retrospective cohort study","volume":"9","author":"Liu","journal-title":"Front Cardiovasc Med"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.02.016","article-title":"Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients","volume":"517","author":"Xie","journal-title":"Clin Chim Acta"},{"issue":"10","key":"R91","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.62347\/ZPZR8134","article-title":"Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn\u2019s disease: correlation with disease severity and biologic efficacy","volume":"16","author":"Xie","journal-title":"Am J Transl Res"},{"issue":"1","key":"R92","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1186\/s12876-025-04357-1","article-title":"Histological remission as a reliable predictor of clinical outcomes in patients with ulcerative colitis after conventional therapy: a 5-year analysis","volume":"25","author":"Tu","journal-title":"BMC Gastroenterol"},{"issue":"S1","key":"R93","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jgh.15953","article-title":"An observational study of methotrexate in inflammatory bowel disease: a small but useful player","volume":"37","author":"McGrory","journal-title":"J Gastroenterology Hepatol"},{"issue":"Supplement_1","key":"R94","doi-asserted-by":"publisher","first-page":"i1809","DOI":"10.1093\/ecco-jcc\/jjad212.1135","article-title":"P1005 Dose escalated infliximab in inflammatory bowel disease - Crohn\u2019s colitis cure (CCC) data insights program","volume":"18","author":"Alshiwanna","journal-title":"J Crohns Colitis"},{"issue":"7","key":"R95","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70207","article-title":"Frequent dietetic involvement enhances adherence and clinical outcomes of exclusive enteral nutrition in adults with Crohn\u2019s disease","volume":"9","author":"Chu","journal-title":"JGH Open"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102875","article-title":"No evidence of disease activity-3 (NEDA-3) status in patients with relapsing remitting multiple sclerosis: evidence from Saudi cohort receiving mainly interferon","volume":"51","author":"Zafar","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"R97","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4103\/sjmms.sjmms_148_24","article-title":"Achievement of no evidence of disease activity-3 with oral disease-modifying treatment in patients with relapsing-remitting multiple sclerosis","volume":"12","author":"Alshamrani","journal-title":"Saudi J Med Med Sci"},{"issue":"1","key":"R98","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09462-z","article-title":"Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia","volume":"23","author":"Alharbi","journal-title":"BMC Health Serv Res"},{"issue":"Supplement_1","key":"R99","doi-asserted-by":"publisher","first-page":"i1895","DOI":"10.1093\/ecco-jcc\/jjad212.1188","article-title":"P1058 Safety and effectiveness of subcutaneous infliximab formulation in difficult-to-treat Crohn\u2019s disease patients with previous exposure to intravenous infliximab: a case-series","volume":"18","author":"Mulinacci","journal-title":"J Crohns Colitis"},{"issue":"Supplement_1","key":"R100","doi-asserted-by":"publisher","first-page":"i1329","DOI":"10.1093\/ecco-jcc\/jjad212.0840","article-title":"P710 Prevalence, characteristics and management of patients with difficult-to-treat inflammatory bowel disease: a cross-sectional study from a tertiary referral center","volume":"18","author":"Parigi","journal-title":"J Crohns Colitis"},{"issue":"9","key":"R101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288393","article-title":"Long-term effectiveness and safety of infliximab-biosimilar: a multicenter Phoenix retrospective cohort study","volume":"18","author":"Kazama","journal-title":"PLoS ONE"},{"issue":"1","key":"R102","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jdi.13631","article-title":"Bariatric surgery versus medical treatment in mildly obese patients with type\u20092 diabetes mellitus in Japan: propensity score-matched analysis on real-world data","volume":"13","author":"Seki","journal-title":"J Diabetes Investig"},{"issue":"9","key":"R103","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s11695-017-2659-9","article-title":"Laparoscopic Silastic Ring Mini-Gastric Bypass (SR-MGBP): up to 11-year results from a single centre","volume":"27","author":"Sheikh","journal-title":"Obes Surg"},{"issue":"10","key":"R104","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/ans.19206","article-title":"Provision and outcomes of publicly funded bariatric surgery in a metropolitan versus a provincial population of New Zealand","volume":"94","author":"Witcomb Cahill","journal-title":"ANZ J Surg"},{"issue":"12","key":"R105","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1185\/03007995.2010.529430","article-title":"Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences","volume":"26","author":"Sicras-Mainar","journal-title":"Curr Med Res Opin"},{"issue":"Supplement_1","key":"R106","doi-asserted-by":"publisher","first-page":"i1039","DOI":"10.1093\/ecco-jcc\/jjad212.0661","article-title":"P531 Long-term evaluation of intensified ustekinumab in Crohn\u2019s disease: real-life results","volume":"18","author":"Molina Arriero","journal-title":"J Crohns Colitis"},{"key":"R107","doi-asserted-by":"publisher","DOI":"10.62401\/2531-4122-2024-54","article-title":"Remission rates of patients with opioid use disorder who got naltrexone implantation: a retrospective study","volume":"26","author":"Dan\u0131sman","journal-title":"HARCP Archives"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102503","article-title":"Bi-temporal electroconvulsive therapy efficacy in bipolar and unipolar depression: a retrospective comparison","volume":"55","author":"Gurel","journal-title":"Asian J Psychiatr"},{"issue":"Supplement_1","key":"R109","doi-asserted-by":"publisher","first-page":"i919","DOI":"10.1093\/ecco-jcc\/jjac190.0915","article-title":"P785 A retrospective cohort study on vedolizumab trough levels in Crohn\u2019s disease patients","volume":"17","author":"Pokryszka","journal-title":"J Crohns Colitis"},{"issue":"11","key":"R110","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1080\/00365521.2021.1965207","article-title":"Long-term clinical outcome after thiopurine discontinuation in elderly IBD patients","volume":"56","author":"Jorissen","journal-title":"Scand J Gastroenterol"},{"key":"R111","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(14)60602-4","article-title":"P482 Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn\u2019s disease","volume":"8","author":"Saleem","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"R112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.10.013","article-title":"Alcohol-related social and health service use patterns as predictors of death and remission in patients with AUD","volume":"96","author":"Rautiainen","journal-title":"J Subst Abuse Treat"},{"key":"R113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1388043","article-title":"Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)","volume":"15","author":"Shehab","journal-title":"Front Pharmacol"},{"issue":"6","key":"R114","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86539","article-title":"Investigating the role of metabolic bariatric surgery in achieving remission of type 2 diabetes mellitus and evaluating the effects on glycemic control and metabolic health","volume":"17","author":"Ahmadi","journal-title":"Cureus"},{"key":"R115","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211024769","article-title":"The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study","volume":"14","author":"Ye","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"R116","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/00365521.2021.1963837","article-title":"Efficacy and safety of rituximab in autoimmune pancreatitis type 1: our experiences and systematic review of the literature","volume":"56","author":"Nikolic","journal-title":"Scand J Gastroenterol"},{"key":"R117","volume":"16","author":"Han","journal-title":"Gut Liver"},{"issue":"1","key":"R118","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2022-100704","article-title":"Adoption of electronic health record systems to enhance the quality of healthcare in low-income countries: a systematic review","volume":"30","author":"Woldemariam","journal-title":"BMJ Health Care Inform"},{"issue":"2","key":"R119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamainternmed.2020.7071","article-title":"Assessment of electronic health record use between US and non-US health systems","volume":"181","author":"Holmgren","journal-title":"JAMA Intern Med"},{"issue":"664","key":"R120","doi-asserted-by":"publisher","first-page":"e775","DOI":"10.3399\/bjgp17X693077","article-title":"The role of the Quality and Outcomes Framework in the care of long-term conditions: a systematic review","volume":"67","author":"Forbes","journal-title":"Br J Gen Pract"},{"key":"R121","doi-asserted-by":"publisher","DOI":"10.2196\/49363","article-title":"The benefits of integrating electronic medical record systems between primary and specialist care institutions: mixed methods cohort study","volume":"27","author":"Goh","journal-title":"J Med Internet Res"},{"issue":"11","key":"R122","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/jamia\/ocae239","article-title":"Electronic health record system use and documentation burden of acute and critical care nurse clinicians: a mixed-methods study","volume":"31","author":"Cho","journal-title":"J Am Med Inform Assoc"},{"issue":"750","key":"R123","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.3399\/BJGP.2024.0036","article-title":"Primary healthcare professionals\u2019 approach to clinical coding: a qualitative interview study in Wales","volume":"75","author":"Davies","journal-title":"Br J Gen Pract"},{"issue":"1","key":"R124","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000474","article-title":"Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study","volume":"3","author":"Beaney","journal-title":"BMJ Med"},{"issue":"1","key":"R125","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","journal-title":"Lancet Respir Med"},{"issue":"1","key":"R126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.anai.2024.09.023","article-title":"Identifying super-responders: a review of the road to asthma remission","volume":"134","author":"Mailhot-Larouche","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"R127","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1111\/jdv.18477","article-title":"Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis Foundation","volume":"36","author":"Balak","journal-title":"Acad Dermatol Venereol"},{"issue":"4","key":"R128","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2213-8587(24)00346-2","article-title":"Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials","volume":"13","author":"Kanbour","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R129","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4743","article-title":"Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data","volume":"372","author":"Goldenberg","journal-title":"BMJ"},{"issue":"3","key":"R130","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","article-title":"Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis","volume":"38","author":"Yu","journal-title":"Clin Rheumatol"},{"issue":"1","key":"R131","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2246","article-title":"Proportion and predictors of remission and recovery in first-episode psychosis: systematic review and meta-analysis","volume":"64","author":"Catalan","journal-title":"Eur Psychiatry"},{"issue":"1","key":"R132","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000542","article-title":"Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review","volume":"8","author":"Ugarte-Gil","journal-title":"Lupus Sci Med"},{"key":"R133","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100247","article-title":"Inequalities in developing multimorbidity over time: a population-based cohort study from an urban, multi-ethnic borough in the United Kingdom","volume":"12","author":"Bisquera","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"R134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20546-4","article-title":"Understanding multimorbidity trajectories in Scotland using sequence analysis","volume":"12","author":"Cezard","journal-title":"Sci Rep"},{"issue":"4","key":"R135","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S2468-2667(24)00028-8","article-title":"Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study","volume":"9","author":"Head","journal-title":"Lancet Public Health"},{"issue":"5","key":"R136","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001220","article-title":"Barriers to the uptake of evidence from systematic reviews and meta-analyses: a systematic review of decision makers\u2019 perceptions","volume":"2","author":"Wallace","journal-title":"BMJ Open"},{"issue":"1","key":"R137","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s41666-023-00153-2","article-title":"Biases in electronic health records data for generating real-world evidence: an overview","volume":"8","author":"Al-Sahab","journal-title":"J Healthc Inform Res"},{"key":"R138","doi-asserted-by":"publisher","DOI":"10.34133\/hds.0176","article-title":"Missing Data in Electronic Health Records (MINDER) group. Moving beyond medical statistics: a systematic review on missing data handling in electronic health records","volume":"4","author":"Ren","journal-title":"Health Data Sci"},{"key":"R139","doi-asserted-by":"publisher","DOI":"10.1177\/26335565221104407","article-title":"Research policy for people with multiple long-term conditions and their carers","volume":"12","author":"Owen","journal-title":"J Multimorb Comorb"},{"issue":"4","key":"R140","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1258\/jhsrp.2011.010124","article-title":"How do we know when research from one setting can be useful in another? A review of external validity, applicability and transferability frameworks","volume":"16","author":"Burchett","journal-title":"J Health Serv Res Policy"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2026\/1\/e80796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:14:26Z","timestamp":1782843266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e80796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":140,"URL":"https:\/\/doi.org\/10.2196\/80796","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"v28i1e80796"}}